倍他乐克联合步长脑心通胶囊治疗冠心病并房颤临床疗效观察(2)
![]() |
第1页 |
参见附件。
[4] Gunnicker M, Brinkmann M, Freund U, et al. Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?[J].Herz,1995,20(6):399-411.
[5] Mendelson G, Aronow WS.Underutilization of beta-blockers in older patients with prior myocardial infarction or coronary artery disease in an academic,hospital-based geriatrics practice[J].J Am Geriatr Soc,1997,45(11):1360-1361.
[6] 賴景涛.倍他乐克、通心络联合治疗冠心病心绞痛的临床疗效观察[J].当代医学,2010,16(21):136-137.
[7] Lamaida N, Capuano V, Di Mauro G, et al. Possible role of beta-blockers in the prevention of sudden cardiac death (SCD) in patients with coronary heart disease(CHD)[J].Panminerva Med,1994,36(2):71-75.
[8] Nozawa T,Inoue H.Treatment with beta-blockers in patients with acute coronary syndrome[J].Nihon Rinsho,1998,56(10):2612-2616.
[9] 王东方,李雪英,赵树红.步长脑心通胶囊对冠心病患者血液流变学及血脂的影响[J].中外医学研究,2011,21(9):13-14.
(收稿日期:2012-09-08)
您现在查看是摘要介绍页,详见PDF附件。